Literature DB >> 18188010

The voice of the patients: allergic rhinitis is not a trivial disease.

Erkka Valovirta1, Svein-Erik Myrseth, Susanna Palkonen.   

Abstract

PURPOSE OF REVIEW: Patient and physician perspectives on the impact of allergic rhinitis have previously been studied in the general population. We evaluated the burden of allergic rhinitis among patients from the members of European allergy patient organizations. The Patient Voice Allergy Survey was a quantitative, self-completion survey of 3562 patients with allergic rhinitis (16 years and older). Background information on allergic rhinitis, severity of allergic rhinitis symptoms and their impact on lives, nonmedical measures for relieving of symptoms, types of medications, and concomitant conditions were evaluated. RECENT
FINDINGS: Almost 50% of the responders reported symptoms lasting for more than a season. Preventive household adjustments are expensive with little perceived benefit. Sleep and emotional life are affected by allergic rhinitis. Most patients are satisfied with the current allergic rhinitis medications; at least one-fifth report dissatisfaction. Patients perceive that allergic rhinitis worsens other concomitant allergic diseases.
SUMMARY: Future management guidelines for allergic rhinitis must take into account the results of this survey. Such guidelines must promote relief from the emotional burden of allergic rhinitis and from the negative impact on daily activities, encourage patient education, and maintain and build on the strong partnership between patients and healthcare professionals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18188010     DOI: 10.1097/ACI.0b013e3282f3f42f

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  40 in total

1.  The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.

Authors:  Waltraud Emminger; María Dolores Hernández; Victòria Cardona; Frank Smeenk; Bodil S Fogh; Moises A Calderon; Frederic de Blay; Vibeke Backer
Journal:  Int Arch Allergy Immunol       Date:  2017-09-27       Impact factor: 2.749

2.  Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach.

Authors:  Ann-Kathrin Richter; Ludger Klimek; Hans F Merk; Norbert Mülleneisen; Harald Renz; Wolfgang Wehrmann; Thomas Werfel; Eckard Hamelmann; Uwe Siebert; Gaby Sroczynski; Jürgen Wasem; Janine Biermann-Stallwitz
Journal:  Eur J Health Econ       Date:  2018-03-24

3.  [The association between allergic rhinitis control and sleep quality].

Authors:  R A Gaudin; L P Hoehle; M-A Birkelbach; K M Phillips; A G Beule; D S Caradonna; S T Gray; A R Sedaghat
Journal:  HNO       Date:  2017-12       Impact factor: 1.284

4.  Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: the Cross-sectional study to evAluate work Productivity in allergic Rhinitis compared with other common dIseases (CAPRI) study.

Authors:  Belén de la Hoz Caballer; Mercedes Rodríguez; Juan Fraj; Inmaculada Cerecedo; Darío Antolín-Amérigo; Carlos Colás
Journal:  Am J Rhinol Allergy       Date:  2012 Sep-Oct       Impact factor: 2.467

5.  Inhibitory Effect of Pycnogenol® on Airway Inflammation in Ovalbumin-Induced Allergic Rhinitis.

Authors:  Ceren Günel; Buket Demirci; Aylin Eryılmaz; Mustafa Yılmaz; İbrahim Meteoğlu; İmran Kurt Ömürlü; Yeşim Başal
Journal:  Balkan Med J       Date:  2016-11-01       Impact factor: 2.021

6.  A Real-Life One-Year Non-Interventional Study Assessing Safety, Tolerability, and Treatment Outcome of the SQ HDM SLIT-Tablet (Acarizax®) in House Dust Mite Allergic Rhinitis With or Without Asthma.

Authors:  Kirsten Sidenius; Peter Arvidsson; Roger Indbryn; Cecilia A Emanuelsson
Journal:  Pulm Ther       Date:  2021-03-27

7.  Assessment of disease control in allergic rhinitis.

Authors:  Pascal Demoly; Moises A Calderon; Thomas Casale; Glenis Scadding; Isabella Annesi-Maesano; Jean-Jacques Braun; Bertrand Delaisi; Thierry Haddad; Olivier Malard; Florence Trébuchon; Elie Serrano
Journal:  Clin Transl Allergy       Date:  2013-02-18       Impact factor: 5.871

8.  The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient survey.

Authors:  Moises A Calderon; Linda Cox; Thomas B Casale; Ralph Mösges; Oliver Pfaar; Hans-Jørgen Malling; Joaquin Sastre; Musa Khaitov; Pascal Demoly
Journal:  Allergy Asthma Clin Immunol       Date:  2015-05-22       Impact factor: 3.406

9.  Managing co-morbid asthma with allergic rhinitis: targeting the one-airway with leukotriene receptor antagonists.

Authors:  Erkka Valovirta
Journal:  World Allergy Organ J       Date:  2012-04-17       Impact factor: 4.084

10.  Escaping the trap of allergic rhinitis.

Authors:  Ilaria Massaro; Marco Caminati; Cristina Quecchia; Filippo Fassio; Enrico Heffler; Giorgio Walter Canonica; Oliviero Rossi
Journal:  Clin Mol Allergy       Date:  2015-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.